US Stock MarketDetailed Quotes

ATOS Atossa Therapeutics

Watchlist

0.9637
-0.0163-1.66%

Close Dec 20 16:00 ET

0.9901
+0.0264+2.74%

Post 19:36 ET

121.23MMarket Cap-4.59P/E (TTM)

Atossa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.33%-4.75M

-1.48%-4.53M

33.10%-4.7M

-0.87%-20.94M

-23.17%-5.57M

28.23%-3.88M

24.95%-4.47M

-43.95%-7.02M

-26.03%-20.76M

-23.41%-4.52M

Net income from continuing operations

-16.07%-7.23M

38.46%-6.05M

6.42%-5.88M

-11.62%-30.09M

-3.51%-7.75M

22.25%-6.23M

-47.35%-9.83M

-31.24%-6.28M

-30.84%-26.96M

-55.03%-7.49M

Operating gains losses

---1K

--2K

----

--3K

--0

Depreciation and amortization

33.33%4K

66.67%5K

187.50%23K

600.00%14K

50.00%3K

-65.22%8K

0.00%2K

Change In working capital

-98.73%18K

50.85%1.16M

132.63%756K

353.59%1.52M

16.12%1.65M

52.04%1.42M

173.10%769K

-21.95%-2.32M

48.18%-599K

413.00%1.42M

-Change in receivables

----

125.84%743K

----

175.29%329K

2.92%-133K

-Change in prepaid assets

-105.11%-153K

132.73%903K

116.99%664K

201.15%2.81M

-474.68%-885K

1,420.81%3M

127.13%388K

122.08%306K

-311.42%-2.77M

74.55%-154K

-Change in payables and accrued expense

189.51%414K

-0.25%400K

102.58%69K

-186.58%-2.12M

-99.63%10K

115.54%143K

-72.38%401K

-235.43%-2.67M

432.46%2.44M

86.89%2.71M

-Change in other current assets

104.18%71K

-11,000.00%-111K

--0

-184.25%-1.7M

--0

-223.96%-1.7M

99.88%-1K

100.88%1K

-14.59%-597K

14.78%-992K

-Change in other current liabilities

-1,156.00%-314K

-68.42%-32K

-50.00%23K

89,300.00%1.78M

22,375.00%1.78M

-525.00%-25K

-205.56%-19K

675.00%46K

-111.76%-2K

-366.67%-8K

Cash from discontinued investing activities

Operating cash flow

-22.33%-4.75M

-1.48%-4.53M

33.10%-4.7M

-0.87%-20.94M

-23.17%-5.57M

28.23%-3.88M

24.95%-4.47M

-43.95%-7.02M

-26.03%-20.76M

-23.41%-4.52M

Investing cash flow

Cash flow from continuing investing activities

-900.00%-10K

76.92%-3K

-6K

99.70%-14K

99.96%-1K

-13K

-52,422.22%-4.73M

-2.01M

Net PPE purchase and sale

-900.00%-10K

76.92%-3K

---6K

48.15%-14K

--0

83.33%-1K

---13K

--0

-200.00%-27K

---8K

Net investment purchase and sale

----

--0

----

---4.7M

---2M

Cash from discontinued investing activities

Investing cash flow

-900.00%-10K

76.92%-3K

---6K

99.70%-14K

--0

99.96%-1K

---13K

--0

-52,422.22%-4.73M

---2.01M

Financing cash flow

Cash flow from continuing financing activities

100K

204K

-1.48M

Net common stock issuance

----

---1.48M

--0

----

--0

Proceeds from stock option exercised by employees

--0

--100K

--204K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

--100K

--204K

---1.48M

--0

---1.48M

--0

Net cash flow

Beginning cash position

-19.96%79.64M

-19.15%84.07M

-20.21%88.57M

-18.67%111M

-19.86%94.14M

-20.81%99.5M

-20.99%103.98M

-18.67%111M

244.11%136.49M

-16.18%117.48M

Current changes in cash

11.18%-4.76M

0.98%-4.43M

35.92%-4.5M

11.99%-22.43M

14.70%-5.57M

33.97%-5.36M

24.73%-4.48M

-43.57%-7.02M

-126.32%-25.49M

-78.25%-6.53M

End cash Position

-20.46%74.88M

-19.96%79.64M

-19.15%84.07M

-20.21%88.57M

-19.86%94.14M

-20.81%99.5M

-20.99%103.98M

-18.67%111M

Free cash flow

-22.55%-4.76M

-1.25%-4.53M

33.01%-4.7M

-0.81%-20.96M

-22.95%-5.57M

28.29%-3.88M

24.73%-4.48M

-43.57%-7.02M

-26.13%-20.79M

-23.63%-4.53M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.33%-4.75M	-1.48%-4.53M	33.10%-4.7M	-0.87%-20.94M	-23.17%-5.57M	28.23%-3.88M	24.95%-4.47M	-43.95%-7.02M	-26.03%-20.76M	-23.41%-4.52M
Net income from continuing operations	-16.07%-7.23M	38.46%-6.05M	6.42%-5.88M	-11.62%-30.09M	-3.51%-7.75M	22.25%-6.23M	-47.35%-9.83M	-31.24%-6.28M	-30.84%-26.96M	-55.03%-7.49M
Operating gains losses	---1K	--2K	--2K	----	----	----	----	----	--3K	--0
Depreciation and amortization	33.33%4K	33.33%4K	66.67%5K	187.50%23K	600.00%14K	50.00%3K	50.00%3K	50.00%3K	-65.22%8K	0.00%2K
Change In working capital	-98.73%18K	50.85%1.16M	132.63%756K	353.59%1.52M	16.12%1.65M	52.04%1.42M	173.10%769K	-21.95%-2.32M	48.18%-599K	413.00%1.42M
-Change in receivables	----	----	----	125.84%743K	----	----	----	----	175.29%329K	2.92%-133K
-Change in prepaid assets	-105.11%-153K	132.73%903K	116.99%664K	201.15%2.81M	-474.68%-885K	1,420.81%3M	127.13%388K	122.08%306K	-311.42%-2.77M	74.55%-154K
-Change in payables and accrued expense	189.51%414K	-0.25%400K	102.58%69K	-186.58%-2.12M	-99.63%10K	115.54%143K	-72.38%401K	-235.43%-2.67M	432.46%2.44M	86.89%2.71M
-Change in other current assets	104.18%71K	-11,000.00%-111K	--0	-184.25%-1.7M	--0	-223.96%-1.7M	99.88%-1K	100.88%1K	-14.59%-597K	14.78%-992K
-Change in other current liabilities	-1,156.00%-314K	-68.42%-32K	-50.00%23K	89,300.00%1.78M	22,375.00%1.78M	-525.00%-25K	-205.56%-19K	675.00%46K	-111.76%-2K	-366.67%-8K
Cash from discontinued investing activities
Operating cash flow	-22.33%-4.75M	-1.48%-4.53M	33.10%-4.7M	-0.87%-20.94M	-23.17%-5.57M	28.23%-3.88M	24.95%-4.47M	-43.95%-7.02M	-26.03%-20.76M	-23.41%-4.52M
Investing cash flow
Cash flow from continuing investing activities	-900.00%-10K	76.92%-3K	-6K	99.70%-14K	0	99.96%-1K	-13K	0	-52,422.22%-4.73M	-2.01M
Net PPE purchase and sale	-900.00%-10K	76.92%-3K	---6K	48.15%-14K	--0	83.33%-1K	---13K	--0	-200.00%-27K	---8K
Net investment purchase and sale	----	----	----	--0	----	----	----	----	---4.7M	---2M
Cash from discontinued investing activities
Investing cash flow	-900.00%-10K	76.92%-3K	---6K	99.70%-14K	--0	99.96%-1K	---13K	--0	-52,422.22%-4.73M	---2.01M
Financing cash flow
Cash flow from continuing financing activities	0	100K	204K	-1.48M	0	-1.48M	0	0	0	0
Net common stock issuance	----	----	----	---1.48M	--0	----	----	----	--0	--0
Proceeds from stock option exercised by employees	--0	--100K	--204K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	--0	--100K	--204K	---1.48M	--0	---1.48M	--0	--0	--0	--0
Net cash flow
Beginning cash position	-19.96%79.64M	-19.15%84.07M	-20.21%88.57M	-18.67%111M	-19.86%94.14M	-20.81%99.5M	-20.99%103.98M	-18.67%111M	244.11%136.49M	-16.18%117.48M
Current changes in cash	11.18%-4.76M	0.98%-4.43M	35.92%-4.5M	11.99%-22.43M	14.70%-5.57M	33.97%-5.36M	24.73%-4.48M	-43.57%-7.02M	-126.32%-25.49M	-78.25%-6.53M
End cash Position	-20.46%74.88M	-19.96%79.64M	-19.15%84.07M	-20.21%88.57M	-20.21%88.57M	-19.86%94.14M	-20.81%99.5M	-20.99%103.98M	-18.67%111M	-18.67%111M
Free cash flow	-22.55%-4.76M	-1.25%-4.53M	33.01%-4.7M	-0.81%-20.96M	-22.95%-5.57M	28.29%-3.88M	24.73%-4.48M	-43.57%-7.02M	-26.13%-20.79M	-23.63%-4.53M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data